|
Volumn 30, Issue 2, 2005, Pages 251-266
|
CpG ODNs treatments of HIV-1 infected patients may cause the decline of transmission in high risk populations - A review, hypothesis and implications
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ALLERGEN;
ALPHA INTERFERON;
BETA INTERFERON;
DNA;
GLYCOPROTEIN GP 120;
HUMAN IMMUNODEFICIENCY VIRUS VACCINE;
IMMUNOGLOBULIN A ANTIBODY;
IMMUNOGLOBULIN E ANTIBODY;
IMMUNOGLOBULIN G ANTIBODY;
INTERLEUKIN 10;
INTERLEUKIN 12;
INTERLEUKIN 13;
INTERLEUKIN 2;
INTERLEUKIN 4;
INTERLEUKIN 5;
OLIGODEOXYRIBONUCLEOTIDE;
SUPERANTIGEN;
TOLL LIKE RECEPTOR 9;
VIRUS PROTEIN;
ACQUIRED IMMUNE DEFICIENCY SYNDROME;
ALLERGY;
AUTOIMMUNE DISEASE;
BASOPHIL;
CLINICAL TRIAL;
CPG ISLAND;
CYTOKINE RELEASE;
DENDRITIC CELL;
DRUG DESIGN;
DRUG SAFETY;
ENDEMIC DISEASE;
HEMATOPOIETIC CELL;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS 1;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
MAST CELL;
NONHUMAN;
PLASMA CELL;
PRIORITY JOURNAL;
PROTEIN BLOOD LEVEL;
PROTEIN DETERMINATION;
PROTEIN DOMAIN;
PROTEIN EXPRESSION;
REVIEW;
SIDE EFFECT;
TH1 CELL;
TH2 CELL;
VIRION;
VIRUS REPLICATION;
VIRUS TRANSMISSION;
ADJUVANTS, IMMUNOLOGIC;
ANIMALS;
CYTOKINES;
HIV INFECTIONS;
HIV-1;
HUMANS;
HYPERSENSITIVITY;
IMMUNOGLOBULIN E;
MEMBRANE GLYCOPROTEINS;
MICE;
MODELS, IMMUNOLOGICAL;
OLIGODEOXYRIBONUCLEOTIDES;
RECEPTORS, CELL SURFACE;
RISK FACTORS;
TH1 CELLS;
TH2 CELLS;
TOLL-LIKE RECEPTOR 9;
TOLL-LIKE RECEPTORS;
|
EID: 14944345375
PISSN: 09208569
EISSN: None
Source Type: Journal
DOI: 10.1007/s11262-004-5632-2 Document Type: Review |
Times cited : (29)
|
References (70)
|